Bjorneklett et al evaluated patients with anti-neutrophil cytoplasmic antibody (ANCA) associated glomerulonephritis. These can help to identify a patient who may require more aggressive management. The authors are from University of Bergen, Haukeland University Hospial and Western Norway University of Applied Sciences.
